REAL-WORLD COMPARISON OF HEALTHCARE COSTS AMONG PATIENTS WITH TYPE 2 DIABETES TREATED WITH DULAGLUTIDE VS. LIRAGLUTIDE IN THE UNITED STATES

被引：0
|
作者：
Mody, R. [1 ]
Huang, Q. [2 ]
Yu, M. [3 ]
Patel, H. [1 ]
Zhao, R. [2 ]
Grabner, M. [2 ]
Lando, Fernandez L. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] HealthCore Inc, Wilmington, DE USA
[3] Eli Lilly & Co, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.520
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB89
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [41] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE AND LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): PATIENT-REPORTED OUTCOMES AT BASELINE
    Boye, K.
    Garcia-Perez, L. E.
    Sapin, H.
    Rosilio, M.
    Federici, Orsini M.
    Heitmann, E.
    Jung, H.
    Gentilella, R.
    Aigner, U.
    Guerci, B.
    Giorgino, F.
    Norrbacka, K.
    VALUE IN HEALTH, 2019, 22 : S593 - S593
  • [42] Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study
    Jain, Akshay B.
    Kanters, Steve
    Khurana, Reena
    Kissock, Jagoda
    Severin, Naomi
    Stafford, Sara G.
    DIABETES THERAPY, 2021, 12 (02) : 527 - 536
  • [43] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE AND LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): COUNTRY-SPECIFIC BASELINE CHARACTERISTICS
    Sapin, H.
    Garcia-Perez, L. E.
    Norrbacka, K.
    Giorgino, F.
    Guerci, B.
    Aigner, U.
    Federici, Orsini M.
    Gentilella, R.
    Heitmann, E.
    Jung, H.
    Rosilio, M.
    Boye, K.
    VALUE IN HEALTH, 2019, 22 : S588 - S588
  • [44] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE & LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): 6-MONTH ANALYSIS RESULTS
    Giorgino, F.
    Guerci, B.
    Garcia-Perez, L. E.
    Boye, K.
    Aigner, U.
    Heitmann, E.
    Federici, Orsini M.
    Zimner-Rapuch, S.
    Rosilio, M.
    Norrbacka, K.
    Sapin, H.
    VALUE IN HEALTH, 2020, 23 : S506 - S506
  • [45] Real -World Healthcare Costs and Resource Utilization Among Patients Treated With Erenumab in the United States: A Retrospective Claims Database Study
    Tepper, Stewart
    Schwedt, Todd
    Vo, Pamela
    Joshi, Parth
    Glassberg, Mrudula
    Abdrabboh, Ahmad
    Ferraris, Matias
    Tiwari, Santosh
    Thompson, Jeffrey
    NEUROLOGY, 2022, 98 (18)
  • [46] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
    Kristina S. Boye
    Hélène Sapin
    Luis-Emilio García-Pérez
    Myriam Rosilio
    Marco Orsini Federici
    Elke Heitmann
    Heike Jung
    Ulrich Aigner
    Bruno Guerci
    Francesco Giorgino
    Kirsi Norrbacka
    Diabetes Therapy, 2020, 11 : 2383 - 2399
  • [47] Liraglutide Effectiveness in Type 2 Diabetes: Insights from a Real-World Cohort of Portuguese Patients
    Silva-Nunes, Jose
    Nascimento, Edite
    Louro, Joana
    Dores, Jorge
    Laginha, Teresa
    Goncalves-Ferreira, Ana
    Alves, Marta
    Souto, Selma B.
    Cunha, Nelson
    Pina, Elsa
    Duarte, Rui
    Raposo, Joao Filipe
    METABOLITES, 2022, 12 (11)
  • [48] Real-world Evaluation of Healthcare Resource Use and Costs of Elderly Patients with Nonvalvular Atrial Fibrillation Treated with Apixaban vs. Warfarin in the US
    Deitelzweig, S.
    Luo, X.
    Gupta, K.
    Trocio, J.
    Mardekian, J.
    Lingohr-Smith, M.
    Menges, B.
    Lin, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S79 - S80
  • [49] Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data study
    Lee, Jiwoo
    Kim, Hwi Seung
    Jung, Chang Hee
    Park, Joong-Yeol
    Lee, Woo Je
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (08)
  • [50] Efficacy and Safety of Once-Weekly Dulaglutide vs. Once-Daily Liraglutide in Japanese Patients with Type 2 Diabetes
    Takamura, Toshinari
    Miyagawa, Jun-Ichiro
    Odawara, Masato
    Takita, Yasushi
    Iwamoto, Noriyuki
    Imaoka, Takeshi
    DIABETES, 2015, 64 : A285 - A285
12345